A new resource to help countries self-assess the adequacy of their regulatory systems to support pharmacy interventions to prevent the harms of substandard and falsified (SF) medicines is launched by the International Pharmaceutical Federation (FIP) today.
Travellers who may have come into contact with a measles case on recent flights between the United States, Auckland and New Plymouth are asked to urgently check the latest public health information on locations of interest – and contact Healthline on 0800 611 116 without delay if they meet the risk criteria.
Source
Media release from Te Whatu Ora - Health New Zealand
A person has been confirmed with measles in Taranaki, after returning to New Zealand from overseas. This follows recent cases linked to a person from Northland and is the thirteenth measles case so far this year.
The seasonally adjusted unemployment rate was 3.9 percent in the September 2023 quarter, compared with 3.6 percent last quarter, according to figures released by Stats NZ today.
AFT Pharmaceuticals (NZX.AFT, ASX.AFP) advises of the release yesterday evening (28 October) by the High Court at Auckland of its judgment upholding in part claims by PBL Solutions Limited (PBL) against AFT, and dismissing others.
At Pharmac’s regular monthly Board meeting held today, the Board endorsed the action plan proposed by the chief executive and senior leadership team to improve the organisation’s culture
Eight top health experts have been appointed to lead Te Whatu Ora and Te Aka Whai Ora’s first National Clinical Networks, being established to reduce variations in access to health services and deliver more consistent health outcomes for New Zealanders, the agencies announced today.
The granting of a licence to cultivate indigenous fungi containing psilocybin, the active compound found in psychedelic mushrooms, is the first of its kind in New Zealand and a major milestone in a Māori health science collaboration led by RangiwahoMarae, based south of Gisborne.
Source
Press release from Rangiwaho Marae and Rua Bioscience
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes